Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting

Introduction: Hyperprogressive disease (HPD) is a state of accelerated tumor growth from cancer immunotherapy, associated with poor outcome. The reported incidence is 6% to 29% among studies using varying definitions of HPD, with no predictive biomarkers. Tumor infiltrating lymphocytes (TILs) are pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanjanapan, Yada, Guduguntla, Geetha, Varikara, Ashwati Krishnan, Szajer, Jeremy, Yip, Desmond, Cockburn, John, Fadia, Mitali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612441/
https://www.ncbi.nlm.nih.gov/pubmed/37885403
http://dx.doi.org/10.1177/15330338231209129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612441/
https://www.ncbi.nlm.nih.gov/pubmed/37885403
http://dx.doi.org/10.1177/15330338231209129

Ejemplares similares